Clinical Trial Update: Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update sponsored by Pacira Pharmaceuticals evaluating chemotherapy for children and young patients with recurrent or refractory meningeal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Leukemia
• Lymphoma
• Solid Tumor

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Brain and Central Nervous System Tumors, Leukemia | Phase 1 | Status: UNKNOWN